Stock SCOL SCANDION ONCOLOGY A/S
Add to a list
To use this feature you must be a member
Log inSign up

Company Scandion Oncology A/S

Equities

SCOL

DK0061031895

Biotechnology & Medical Research

Delayed Nasdaq Stockholm
Other stock markets
 06:50:11 2024-05-14 am EDT 		5-day change 1st Jan Change
1.445 SEK +3.96% Intraday chart for Scandion Oncology A/S +8.65% -63.83%
Mar. 21 Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival CI
Mar. 07 Scandion Oncology Reports Second Confirms Partial Response in the Phase IIa CORIST Part 3 Trial CI

Business Summary

Scandion Oncology A/S is a manufacturer of biological products. The Company was founded in May 2017 and is located in Copenhagen, Denmark. It focuses on modern onclogy, the treatment of cancers that have developed resistance to chemotherapy.

Number of employees: 4

Managers

Managers TitleAgeSince
Jan Stenvang FOU
 Founder - 16-12-31
François Martelet CEO
 Chief Executive Officer 64 23-01-01
Johnny Stilou DFI
 Director of Finance/CFO 57 21-07-31
Lars Damstrup CTO
 Chief Tech/Sci/R&D Officer - 22-12-31
Peter Michael Vestlev PRN
 Corporate Officer/Principal - -
Morten Nissen LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Alejandra Maria Mørk BRD
 Director/Board Member 63 22-03-31
Jørgen Vilhelm Bardenfleth BRD
 Director/Board Member 69 18-05-06
Martin Møller CHM
 Chairman 49 21-04-30
Martine van Vugt BRD
 Director/Board Member 71 22-03-31
Keld Flintholm Jørgensen BRD
 Director/Board Member 53 22-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 40,706,972 38,542,097 ( 94.68 %) 0 94.68 %

Shareholders

NameEquities%Valuation
Tellus Fonder AB
0.2489 %
101,306 0.2489 % 12 414 kr

Company contact information

Scandion Oncology A/S

Symbion Fruebjergvej 3

2100, Copenhagen

+45 38 10 20 17

http://www.scandiononcology.com
address Scandion Oncology A/S(SCOL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
SCANDION ONCOLOGY A/S Stock Scandion Oncology A/S
-63.83% 5.22M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+5.66% 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.23% 105B
ARGENX SE Stock argenx SE
-2.68% 21.93B
BIONTECH SE Stock BioNTech SE
-12.15% 22.34B
GENMAB A/S Stock Genmab A/S
-5.61% 18.59B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-36.52% 18.12B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.09% 16.96B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.33% 13.7B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.58% 12.45B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. SCOL Stock
  4. Company Scandion Oncology A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW